Works matching IS 15747891 AND DT 2024 AND VI 18 AND IP 10
Results: 40
ERBB2 mutations define a subgroup of endometrial carcinomas associated with high tumor mutational burden and the microsatellite instability‐high (MSI‐H) molecular subtype.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 10, p. 2356, doi. 10.1002/1878-0261.13698
- By:
- Publication type:
- Article
Expression of Concern: T‐LAK cell‐originated protein kinase (TOPK): an emerging prognostic biomarker and therapeutic target in osteosarcoma.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 10, p. 2601, doi. 10.1002/1878-0261.13711
- Publication type:
- Article
Immune evasion: An imperative and consequence of MYC deregulation.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 10, p. 2338, doi. 10.1002/1878-0261.13695
- By:
- Publication type:
- Article
RETRACTION: CircRNA EPHB4 modulates stem properties and proliferation of gliomas via sponging miR‐637 and up‐regulating SOX10.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 10, p. 2603, doi. 10.1002/1878-0261.13693
- Publication type:
- Article
RETRACTION: The Sp1/FOXC1/HOTTIP/LATS2/YAP/β‐catenin cascade promotes malignant and metastatic progression of osteosarcoma.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 10, p. 2602, doi. 10.1002/1878-0261.13692
- Publication type:
- Article
Slow‐replicating leukemia cells represent a leukemia stem cell population with high cell‐surface CD74 expression.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 10, p. 2554, doi. 10.1002/1878-0261.13690
- By:
- Publication type:
- Article
PRRX1 silencing is required for metastatic outgrowth in melanoma and is an independent prognostic of reduced survival in patients.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 10, p. 2471, doi. 10.1002/1878-0261.13688
- By:
- Publication type:
- Article
A combination of protein phosphatase 2A inhibition and checkpoint immunotherapy: a perfect storm.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 10, p. 2333, doi. 10.1002/1878-0261.13687
- By:
- Publication type:
- Article
Endometrioid ovarian carcinoma landscape: pathological and molecular characterization.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 10, p. 2586, doi. 10.1002/1878-0261.13679
- By:
- Publication type:
- Article
Septin 9 expression regulates 'don't eat me' signals and identifies an immune–epithelial class of intrahepatic cholangiocarcinoma.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 10, p. 2369, doi. 10.1002/1878-0261.13673
- By:
- Publication type:
- Article
Interferon regulatory factor 4 modulates epigenetic silencing and cancer‐critical pathways in melanoma cells.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 10, p. 2423, doi. 10.1002/1878-0261.13672
- By:
- Publication type:
- Article
Targeting chondroitin sulfate suppresses macropinocytosis of breast cancer cells by modulating syndecan‐1 expression.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 10, p. 2569, doi. 10.1002/1878-0261.13667
- By:
- Publication type:
- Article
CDK12‐inactivation‐induced MYC signaling causes dependency on the splicing kinase SRPK1.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 10, p. 2510, doi. 10.1002/1878-0261.13666
- By:
- Publication type:
- Article
Exploring the molecular landscape of cancer of unknown primary: A comparative analysis with other metastatic cancers.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 10, p. 2393, doi. 10.1002/1878-0261.13664
- By:
- Publication type:
- Article
Unveiling the dynamics and molecular landscape of a rare chronic lymphocytic leukemia subpopulation driving refractoriness: insights from single‐cell RNA sequencing.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 10, p. 2541, doi. 10.1002/1878-0261.13663
- By:
- Publication type:
- Article
Loss of p14 diminishes immunogenicity in melanoma via non‐canonical Wnt signaling by reducing the peptide surface density.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 10, p. 2449, doi. 10.1002/1878-0261.13660
- By:
- Publication type:
- Article
Spliceosomic dysregulation in pancreatic cancer uncovers splicing factors PRPF8 and RBMX as novel candidate actionable targets.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 10, p. 2524, doi. 10.1002/1878-0261.13658
- By:
- Publication type:
- Article
Benign breast tumors may arise on different immunological backgrounds.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 10, p. 2495, doi. 10.1002/1878-0261.13655
- By:
- Publication type:
- Article
Oncogenic composite mutations can be predicted by co‐mutations and their chromosomal location.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 10, p. 2407, doi. 10.1002/1878-0261.13636
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 10, p. 2331, doi. 10.1002/1878-0261.13464
- Publication type:
- Article
Expression of Concern: T‐LAK cell‐originated protein kinase (TOPK): an emerging prognostic biomarker and therapeutic target in osteosarcoma.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 10, p. 2601, doi. 10.1002/1878-0261.13711
- Publication type:
- Article
ERBB2 mutations define a subgroup of endometrial carcinomas associated with high tumor mutational burden and the microsatellite instability‐high (MSI‐H) molecular subtype.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 10, p. 2356, doi. 10.1002/1878-0261.13698
- By:
- Publication type:
- Article
Immune evasion: An imperative and consequence of MYC deregulation.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 10, p. 2338, doi. 10.1002/1878-0261.13695
- By:
- Publication type:
- Article
RETRACTION: CircRNA EPHB4 modulates stem properties and proliferation of gliomas via sponging miR‐637 and up‐regulating SOX10.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 10, p. 2603, doi. 10.1002/1878-0261.13693
- Publication type:
- Article
RETRACTION: The Sp1/FOXC1/HOTTIP/LATS2/YAP/β‐catenin cascade promotes malignant and metastatic progression of osteosarcoma.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 10, p. 2602, doi. 10.1002/1878-0261.13692
- Publication type:
- Article
Slow‐replicating leukemia cells represent a leukemia stem cell population with high cell‐surface CD74 expression.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 10, p. 2554, doi. 10.1002/1878-0261.13690
- By:
- Publication type:
- Article
PRRX1 silencing is required for metastatic outgrowth in melanoma and is an independent prognostic of reduced survival in patients.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 10, p. 2471, doi. 10.1002/1878-0261.13688
- By:
- Publication type:
- Article
A combination of protein phosphatase 2A inhibition and checkpoint immunotherapy: a perfect storm.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 10, p. 2333, doi. 10.1002/1878-0261.13687
- By:
- Publication type:
- Article
Exploring the molecular landscape of cancer of unknown primary: A comparative analysis with other metastatic cancers.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 10, p. 2393, doi. 10.1002/1878-0261.13664
- By:
- Publication type:
- Article
Septin 9 expression regulates 'don't eat me' signals and identifies an immune–epithelial class of intrahepatic cholangiocarcinoma.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 10, p. 2369, doi. 10.1002/1878-0261.13673
- By:
- Publication type:
- Article
Interferon regulatory factor 4 modulates epigenetic silencing and cancer‐critical pathways in melanoma cells.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 10, p. 2423, doi. 10.1002/1878-0261.13672
- By:
- Publication type:
- Article
Targeting chondroitin sulfate suppresses macropinocytosis of breast cancer cells by modulating syndecan‐1 expression.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 10, p. 2569, doi. 10.1002/1878-0261.13667
- By:
- Publication type:
- Article
CDK12‐inactivation‐induced MYC signaling causes dependency on the splicing kinase SRPK1.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 10, p. 2510, doi. 10.1002/1878-0261.13666
- By:
- Publication type:
- Article
Endometrioid ovarian carcinoma landscape: pathological and molecular characterization.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 10, p. 2586, doi. 10.1002/1878-0261.13679
- By:
- Publication type:
- Article
Unveiling the dynamics and molecular landscape of a rare chronic lymphocytic leukemia subpopulation driving refractoriness: insights from single‐cell RNA sequencing.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 10, p. 2541, doi. 10.1002/1878-0261.13663
- By:
- Publication type:
- Article
Loss of p14 diminishes immunogenicity in melanoma via non‐canonical Wnt signaling by reducing the peptide surface density.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 10, p. 2449, doi. 10.1002/1878-0261.13660
- By:
- Publication type:
- Article
Spliceosomic dysregulation in pancreatic cancer uncovers splicing factors PRPF8 and RBMX as novel candidate actionable targets.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 10, p. 2524, doi. 10.1002/1878-0261.13658
- By:
- Publication type:
- Article
Benign breast tumors may arise on different immunological backgrounds.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 10, p. 2495, doi. 10.1002/1878-0261.13655
- By:
- Publication type:
- Article
Oncogenic composite mutations can be predicted by co‐mutations and their chromosomal location.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 10, p. 2407, doi. 10.1002/1878-0261.13636
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 10, p. 2331, doi. 10.1002/1878-0261.13464
- Publication type:
- Article